Gunilla Christina Osswald
Chief Executive Officer at BIOARCTIC AB
Net worth: 2 M $ as of 31/05/2024
Network origin in Gunilla Christina Osswald first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden.
40
| Subsidiary | Miscellaneous Commercial Services | 40 |
| Public Company | Pharmaceuticals: Major | 25 | |
22
| Public Company | Pharmaceuticals: Major | 22 |
Lpb Sweden AB
 Lpb Sweden AB Real Estate DevelopmentFinance Lpb Sweden AB provides movable and immovable property services. The private company is based in Stockholm, Sweden.
2
| Private Company | Real Estate Development | 2 |
Spinemedical AB
 Spinemedical AB Medical/Nursing ServicesHealth Services Spinemedical AB provides surgical treatment and rehabilitation services. The private company is based in Stockholm, Sweden.
1
| Private Company | Medical/Nursing Services | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Gunilla Christina Osswald via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| University of Uppsala | College/University | Karin Helena Johansson Wingstrand | Graduate Degree Doctorate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Doctorate Degree Graduate Degree Corporate Officer/Principal Graduate Degree Doctorate Degree Graduate Degree Graduate Degree Graduate Degree Doctorate Degree Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree |
| Karolinska Institutet | College/University | Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Undergraduate Degree | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal Chief Executive Officer Director of Finance/CFO Public Communications Contact Corporate Officer/Principal Comptroller/Controller/Auditor Corporate Officer/Principal Investor Relations Contact Compliance Officer | |
| University of Stockholm | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Doctorate Degree Masters Business Admin | |
| Stockholm School of Economics | College/University | Masters Business Admin Masters Business Admin Undergraduate Degree Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
| RECIPHARM AB (PUBL) | Biotechnology | Director of Finance/CFO Director/Board Member Director/Board Member Corporate Officer/Principal Chief Operating Officer Corporate Officer/Principal | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| SWEDISH ORPHAN BIOVITRUM AB | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Corporate Officer/Principal Investor Relations Contact Public Communications Contact Director/Board Member | |
| University of Gothenburg | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree | |
| MEDIVIR AB | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Royal Institute of Technology | College/University | Doctorate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
| XSPRAY PHARMA AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Investor Relations Contact | |
Spinemedical Sverige AB
 Spinemedical Sverige AB Miscellaneous Commercial ServicesCommercial Services Spinemedical Sverige AB provides research and development services on surgical treatment. The private company is based in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chief Executive Officer Chairman | |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Graduate Degree | |
| KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Operating Officer Chief Tech/Sci/R&D Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Royal Swedish Academy of Engineering Sciences
 Royal Swedish Academy of Engineering Sciences Miscellaneous Commercial ServicesCommercial Services The Royal Swedish Academy of Engineering Sciences (IVA) is an organization that brings together around 1,300 academy members and 250 companies to bridge the gap between academia, business, and politics. The non-profit company is based in Stockholm, Sweden. The Swedish company's aim is to work towards people's ability to contribute positively to society. The organization runs an internship program called Tekniksprånget, which gives young people in Sweden the opportunity to test the engineering profession through a four-month paid internship. The program has been running since 2012 and aims to inspire more people to choose a higher technical education. The CEO of the company is Björn O. Nilsson. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
AnaMar AB
 AnaMar AB Pharmaceuticals: MajorHealth Technology AnaMar AB develops drugs and provides research services for chronic joint diseases. It focuses on the discovery, development and commercialization of novel therapeutic strategies to treat debilitating inflammation and pain. The company was founded in 1998 and is headquartered in Lund, Sweden. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
Apotek Produktion & Laboratorier AB
 Apotek Produktion & Laboratorier AB Pharmaceuticals: MajorHealth Technology Apotek Produktion & Laboratorier AB develops and manufactures pharmaceutical products. Its services include analytical services, clinical trials and contract manufacturing. The company is headquartered in Kungens Kurva, Sweden. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Chief Executive Officer | |
| FLERIE INVEST AB | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member | |
| Recipharm Stockholm AB | Director/Board Member Chairman Director/Board Member | ||
Modus Therapeutics AB
 Modus Therapeutics AB Pharmaceuticals: MajorHealth Technology Modus Therapeutics AB operates as a clinical-stage drug development company that develops new pharmaceutical therapies designed to restore impaired blood flow and oxygen transport in diseases with unmet medical needs. The firm’s product Sevuparin, evaluates in a phase II clinical trial in sickle cell disease (SCD) and repeated painful crises in SCD, so called vaso-occlusive crises (VOC) that leads to loss of vital organ function and reduced life span. The company was founded by Carl Mats Wahlgren in 2011 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Chief Executive Officer | |
Entasis Therapeutics, Inc.
 Entasis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Entasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovey, development, and commercialization of novel antibacterial prodcuts to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its pipeline includes ETX2514SUL, targeting Acinetobacter baumannii infections; ETX0282CPDP, targeting Enterobacteriaceae infections; a Non-Beta-lactam PBP inhibitor, targeting Gram-negative infections; and zoliflodacin, targeting Neisseria gonorrhoeae. The company was founded by Manoussos Perros in May 2015 and is headquartered in Waltham, MA. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
A3P Biomedical AB
 A3P Biomedical AB Medical/Nursing ServicesHealth Services A3P Biomedical AB is a Swedish company that aims to improve the precision in prostate cancer diagnostics and treatment. A3P Biomedical is headquartered in Sweden and has subsidiaries in the country. The private company's lead product is Stockholm3, a blood test for early detection of aggressive prostate cancer. The test has been developed by scientists at Institutet and validated in clinical studies involving more than 80,000 men. A total of SEK 750 million has been invested in clinical research, product development, and market validation activities. The company sells Stockholm3 to healthcare providers through direct sales and distributors. | Medical/Nursing Services | Director/Board Member Director/Board Member Director of Finance/CFO | |
SwedenBIO Service AB
 SwedenBIO Service AB Miscellaneous Commercial ServicesCommercial Services SwedenBIO Service AB is a non-profit company that develops biotechnology, diagnostics, pharmaceuticals, and medical technology. It also offers counseling, education, opinion formation, and investigations. The company was founded in 2002 and is headquartered in Stockholm, Sweden. | Miscellaneous Commercial Services | Director/Board Member Chairman Director/Board Member | |
| ENTASIS THERAPEUTICS HOLDINGS INC. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| SPAGO NANOMEDICAL AB | Biotechnology | Chairman Chairman Director/Board Member | |
| AROCELL AB | Medical Specialties | Director/Board Member Director/Board Member Director/Board Member | |
Stockholm Chamber of Commerce
 Stockholm Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services Stockholm Chamber of Commerce is a member of Swedish Chambers International, which is an umbrella organization for Swedish Chambers of Commerce abroad. The Chamber of Commerce in Stockholm provides contact information for those who are unsure of who to contact regarding their matter. The non-profit company is based in Stockholm, Sweden, and has subsidiaries in Sweden. The purpose of SCI is to strengthen the brand internationally, facilitate business for companies, and exchange experiences. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Karolinska Institutet Holding AB
 Karolinska Institutet Holding AB Investment Trusts/Mutual FundsMiscellaneous Part of Karolinska Institutet Holding AB, Nätverk Karolinska Institutet Science Park AB (KISP) facilitates interaction between academia and industry on Campus Solna. The company is based in Solna, Sweden. KISP collaborates closely with Karolinska Institutet, Akademiska Hus, and AWL to organize seminars, workshops, and networking events that help researchers, startups, and established companies connect and gain new insights. The CEO of the Swedish company is Karl Johan Ingvar Weigelt. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member | |
Forska Sverige
 Forska Sverige Miscellaneous Commercial ServicesCommercial Services Forska Sverige provides medical research services. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman General Counsel | |
| Swedish Pharmaceutical Society | Chairman Chairman | ||
NovaSAID AB
 NovaSAID AB Pharmaceuticals: MajorHealth Technology NovaSAID AB develops treatments for inflammation and pain in conditions such as rheumatoid arthritis. It discovers selective microsomal prostaglandin E synthase-1 (mPGES-1), and has also demonstrated its effect in animal models for pain and inflammation. The firm's approach is to prevent the pathological formation of prostaglandin E2 (PGE2) selectively, through the development of inhibitors of mPGES-1, the enzyme that is responsible for the formation of PGE2 during inflammation. Its mPGES-1 inhibition offers an approach for inhibiting pathological PGE2 production without adversely affecting other important prostanoids. The company was founded by Per-Johan Göte Jakobsson, Ralf Morgenstern, Bertil Samuelsson and Bengt Ingemar Samuelsson on October 26, 2004 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Chairman | |
EpiEndo Pharmaceuticals ehf
 EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Director/Board Member Chief Executive Officer | |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Corporate Officer/Principal | |
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Biosergen AS develops drugs based on biosynthetic engineering of natural products, combined with chemical synthesis. It develops antibiotics for the use in antifungal therapy. The firm uses engineered biosynthesis technology that allows alterations in microbial genes, which lead to predictable changes in the final structure of the natural product. The company was founded in 2004 and is headquartered in Tiller, Norway. | Biotechnology | Chief Executive Officer Chief Executive Officer | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Chairman Director/Board Member | |
| SYNACT PHARMA AB | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| KARO PHARMA AB (PUBL) | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Immedica Pharma AB
 Immedica Pharma AB Pharmaceuticals: MajorHealth Technology Immedica Pharma AB provides know-how and access of specialty care medicine and products. It also provides information on regulatory and medical affairs and product distribution. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Chairman Founder | |
LEO Pharma A/S
 LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| BIOGAIA AB | Pharmaceuticals: Other | Compliance Officer Director/Board Member | |
Palette Life Sciences AB
 Palette Life Sciences AB Medical SpecialtiesHealth Technology Palette Life Sciences AB operates as a pharmaceutical company. It specializes in developing products for local pain relief in obstetrics and gynecology. The company was founded by Berith Karlsson Tingåker, Gunvor Ekman-Ordeberg, Arne Folke Brodin and Lars Irestedt in 2009 and is headquartered in Solna, Sweden. | Medical Specialties | Director/Board Member Director/Board Member | |
| INFANT BACTERIAL THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Chairman Director of Finance/CFO |
Statistics
International
| Sweden | 44 |
| United States | 3 |
| Denmark | 3 |
| United Kingdom | 2 |
| Iceland | 2 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 9 |
| Commercial Services | 7 |
| Finance | 2 |
| Health Services | 2 |
Operational
| Director/Board Member | 399 |
| Corporate Officer/Principal | 198 |
| Chairman | 116 |
| Chief Executive Officer | 90 |
| Independent Dir/Board Member | 68 |
Most connected contacts
- Stock Market
- Insiders
- Gunilla Christina Osswald
- Company connections
